%0 Journal Article
%T A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
%A Di Wu
%A Fang Lou
%A Haiyan Wu
%A Hongming Pan
%A Jianfeng Li
%A Jiwei Liu
%A Jun Ge
%A Jun Guo
%A Lili Mao
%A Lingjun Zhu
%A Lu Si
%A Scott J. Diede
%A Shijie Lan
%A Xiaoshi Zhang
%A Xin Cai
%A Xizhi Wen
%A Xuan Wang
%A Yanhong Gu
%A Yongqian Shu
%A Yu Zhou
%J Archive of "Translational Oncology".
%D 2019
%R 10.1016/j.tranon.2019.02.007
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458446/